Charles River Laboratories International, Inc. (CRL)
335.52
-2.45
(-0.72%)
USD |
NYSE |
Nov 16, 16:00
330.82
-4.70
(-1.40%)
After-Hours: 20:00
Charles River Laboratories International Enterprise Value : 18.74B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 18.74B |
| November 13, 2026 | 18.85B |
| November 12, 2026 | 18.99B |
| November 11, 2026 | 19.08B |
| November 10, 2026 | 19.23B |
| November 09, 2026 | 19.59B |
| November 06, 2026 | 18.83B |
| November 05, 2026 | 17.66B |
| November 04, 2026 | 18.29B |
| November 03, 2026 | 19.52B |
| November 02, 2026 | 18.88B |
| October 30, 2026 | 19.88B |
| October 29, 2026 | 20.68B |
| October 28, 2026 | 20.58B |
| October 27, 2026 | 19.85B |
| October 26, 2026 | 19.78B |
| October 23, 2026 | 19.21B |
| October 22, 2026 | 18.93B |
| October 21, 2026 | 19.18B |
| October 20, 2026 | 17.78B |
| October 19, 2026 | 17.04B |
| October 16, 2026 | 17.04B |
| October 15, 2026 | 17.33B |
| October 14, 2026 | 17.13B |
| October 13, 2026 | 16.99B |
| Date | Value |
|---|---|
| October 12, 2026 | 17.12B |
| October 09, 2026 | 17.12B |
| October 08, 2026 | 16.94B |
| October 07, 2026 | 17.05B |
| October 06, 2026 | 17.27B |
| October 05, 2026 | 17.55B |
| October 02, 2026 | 16.57B |
| October 01, 2026 | 16.40B |
| September 30, 2026 | 16.80B |
| September 29, 2026 | 16.99B |
| September 28, 2026 | 16.93B |
| September 25, 2026 | 16.84B |
| September 24, 2026 | 16.92B |
| September 23, 2026 | 16.10B |
| September 22, 2026 | 16.47B |
| September 21, 2026 | 16.18B |
| September 18, 2026 | 16.14B |
| September 17, 2026 | 16.31B |
| September 16, 2026 | 15.92B |
| September 15, 2026 | 15.89B |
| September 14, 2026 | 15.90B |
| September 11, 2026 | 16.15B |
| September 10, 2026 | 15.90B |
| September 09, 2026 | 16.15B |
| September 08, 2026 | 16.27B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fortrea Holdings, Inc. | 2.808B |
| IQVIA Holdings, Inc. | 57.65B |
| Medpace Holdings, Inc. | 17.55B |
| Champions Oncology, Inc. | 72.32M |
| Avantor, Inc. | 13.60B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 334.44M |
| Revenue (Quarterly) | 982.73M |
| Total Expenses (Quarterly) | 649.66M |
| EPS Diluted (Quarterly) | 6.856 |
| Gross Profit Margin (Quarterly) | 35.64% |
| Profit Margin (Quarterly) | 34.03% |
| Earnings Yield | 0.27% |
| Operating Earnings Yield | 3.74% |
| Normalized Earnings Yield | 2.296 |